LEXINGTON, Mass., May 2, 2023 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ:PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and central nervous system disease using its patented iSPERSEâ„¢ technology, today announced its support for World Asthma Day.
Read more at prnewswire.comPulmatrix Supports World Asthma Day 2023
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here